Acta Medica Iranica 2016. 54(11):713-717.

Risk Factors and Consequent Outcomes of Placenta Previa: Report From a Referral Center
Soraya Saleh Gargari, Zahra Seify, Ladan Haghighi, Maryam Khoshnood Shariati, Masoumeh Mirzamoradi



Because of an unknown factor, the frequency of complicated pregnancy with placenta previa has been raised during past decade. This study was designed to deepen our understanding of risk factors and outcomes of placenta previa in our country. This study investigated 694 cases of placenta previa comparing with 600 healthy pregnant women with not overlie placenta in two referral and tertiary Obstetrics and Gynecological Hospital in Iran on the basis of the clinical and para-clinical analysis, in order to find the probable risk factors for occurrence of placenta previa and its effect on maternal and neonatal complications. The most important risk factor for the occurrence of placenta previa was advanced maternal age (P<0.001) and history of stillbirth (OR=117.2, CI=58.3-236.0). In the other hand, the most substantial outcome of this disorder was a reduction of gestational age (P<0.001) and low birth weight neonatally (P<0.001). The conservative follow-up should be programmed for women with placenta previa based on the type of risk factors which can provide the best possible management to decrease the morbidity and mortality of their related complications.


Anormal placentation; Peripatrum hysterectomy; Caesarean section; Obstetric haemorrhage

Full Text:



Blackwell SC. The timing of delivery for women with stable placenta previa. Semin Perinatol 2011;35:249-51.

Daskalakis G, Simou M, Zacharakis D, Detorakis S, Akrivos N, Papantoniou N, et al. Impact of placenta previa on obstetric outcome. Int J Gynaecol Obstet 2011;114:238-41.

Rao KP, Belogolovkin V, Yankowitz J, Spinnato JA 2nd.Abnormal placentation: evidence-based diagnosis and management of placenta previa, placenta accreta, and vasa previa. Obstet Gynecol Surv 2012;67:503-19.

O'Brien JM. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2007;109:203-4.

Crane JM, Van den Hof MC, Dodds L, Armson BA,Liston R. Maternal complications with placenta previa. Am J Perinatol 2000;17:101-5.

Bose DA, Assel BG, Hill JB, Chauhan SP. Maintenance tocolytics for preterm symptomatic placenta previa: a review. Am J Perinatol 2011;28:45-50.

Hasegawa J, Nakamura M, Hamada S, Matsuoka R, Ichizuka K, Sekizawa A, et al. Prediction of hemorrhage in placenta previa. Taiwan J Obstet Gynecol 2012;51:3-6.

Taki M, Sato Y, Kakui K, Tatsumi K, Fujiwara H, Konishi I. Management of fetal death with placenta previa. J Matern Fetal Neonatal Med 2012;25:196-9.

Cunningham F, Gant N, Leveno K, et al, eds. Williams Obstetrics. 23st ed. New York: McGraw Hill, 2010:770.

Cotton DB, Read JA, Paul RH, Quilligan EJ. The conservative aggressive management of placenta previa. Am J Obstet Gynecol 1980;137:687-95.

Committee on Obstetric Practice. ACOG committee opinion. Placenta accreta. Number 266, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol obstet 2002;77:77-8.

Karavolos S, Al-Habib A, Madgwick K, Fakokunde A, Okolo S, Yoong W. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 2007;114:117-8.

Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 2006;113:919-24.

Besinger RE, Moniak CW, Paskiewicz LS, Fisher SG, Tomich PG. The effect of tocolytic use in the management of symptomatic placenta previa. Am J Obstet Gynecol 1995;172:1770-5.

Sharma A, Suri V, Gupta I. Tocolytic therapy in conservative management of symptomatic placenta previa. Int J Gynaecol Obstet 2004;84:109-13.

Neilson JP. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Obstet Gynecol 2007;109:189-90.

Rosenberg T, Pariente G, Sergienko R, Wiznitzer A, Sheiner E. Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet 2011;284:47-51.

Zhang L, Li P, He GL, Liu XH, Yang TZ, Luo H, et al.Value of prenatal diagnosis of placenta previa with placenta increta by transabdominal color Doppler ultrasound. Zhonghua Fu Chan Ke Za Zhi 2006;41:799-802.

Jahromi BN, Husseini Z. Pregnancy outcome at maternal age 40 and older. Taiwan J Obstet Gynecol 2008;47:318-1.

Tuzovic L. Complete versus incomplete placenta previa and obstetric outcome. Int J Gynaecol Obstet 2006;93:110-7.

Grobman WA, Gersnoviez R, Landon MB, Spong CY, Leveno KJ, Rouse DJ, et al. Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol 2007;110:1249-55.

Yaegashi N, Chiba-Sekii A, Okamura K. Emergency postpartum hysterectomy in women with placenta previa and prior cesarean section. Int J Gynaecol Obstet 2000;68:49-52.

Choi SJ, Song SE, Jung KL, Oh SY, Kim JH, Roh CR.Antepartum risk factors associated with peripartum cesarean hysterectomy in women with placenta previa. Am J Perinatol 2008;25:37-41.

Zaki ZM, Bahar AM, Ali ME, Albar HA, Gerais MA.Risk factors and morbidity in patients with placenta previa accreta compared to placenta previa non-accreta. Acta Obstet Gynecol Scand 1998;77:391-4.

Dola CP, Garite TJ, Dowling DD, Friend D, Ahdoot D, Asrat T. Placenta previa: does its type affect pregnancy outcome? Am J Perinatol 2003;20:353-60.

Liang-Kun M, Na N, Jian-Qiu Y, Xu-Ming B, Jun-Tao L.Clinical analysis of placenta previa complicated with previous caesarean section. Chin Med Sci J 2012;27:129-33.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.